Healthcast 609 – The Galleri® Cancer Early Detection Test

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog/

BioBalance Health® has always been on the cutting edge of the newest medical methodology available. In the fight against cancer, we are now using he newest genetic methodology to find cancers early, when they are treatable. Throughout my almost 40 years of practicing medicine, I have believed that medicine should embrace preventive care and be based on the belief that we should only react to a disease that is already established. Now we finally have one test that screens for 72% of the cancers that we can't screen for. It is hard to believe that out of the 55 types of cancer we can only screen for 5 Cancers! Medicine has only developed 5 screening tests that are currently in use to find cancers early.

Galleri is one simple blood test that screens for 50 types of cancer, to find them at early treatable stages, before they create symptoms, metastasize, or produce any symptoms. Galleri was created for those patients who have a positive family history of cancer, or those patients who are fearful of getting cancer of any type, and for those patients who have been successfully treated for cancer who want to find out early, if they have a recurrence!

Galleri It is the dream child of a company who has been testing and retesting it with the finest geneticists in the US. We are offering this test through our office as an option for those who need it to truly practice preventive medicine! With Galleri, you have a good chance of being cured of cancer through very early detection!

Before Galleri® was invented patients only had 5 cancers that could be detected early by screening tests. The following list enumerates the 5 cancers we have screening tests for.

1. Breast cancer: Mammography can find cancer after it has been growing for 11 years.
2. Cervical Cancer: Pap and HPV Test only finds the virus and possibly the cells that might be cancer.
3. Colorectal Cancer, Colon Cancer: Colonoscopy and stool tests
4. Lung Cancer: Low Dose C-T Scan
5. Prostate Cancer: PSA Test

Routine screening tests are recommended because they have been proven to save lives by detecting some cancers earlier.3 The Galleri test does not preclude the use of the 5 screening tests that are currently in use, however there are more than 50 cancers that Galleri® can test for, and you receive your results in 10 working days.

It is time to look at cancer more broadly, in addition to the 5 cancers that are routinely screened for today.

The most important cancer is the one that you or your loved one may have — and curing cancer starts with knowing you have it!

If cancer runs in your family, and you lose sleep worrying about it you should take the Galleri® Test. If your genetic relatives (father mother, aunt or uncle, sisters or brothers or children have had cancer then testing yourself for cancer with Galleri® will answer the question as to whether you have it or not.

Our patients at BioBalance Health® are offered this test yearly for high-risk patients and as needed, often less often than yearly. The test is not covered by insurance as it is a new test…but can you wait until it is covered? Worrying about cancer can make you literally sick by stimulating your adrenal gland's production of cortisol. This worry impairs your immune system that protects you from cancer, putting you at higher risk!

The only risk of Galleri® is the cost…$ 1,250 paid directly to the Galleri® company at the time of your blood draw.

50 Types of cancer detected by Galleri®

The Galleri test is a multicancer early detection test that detects a common cancer signal across more than 50 types of cancer through a simple blood draw.

A

Adrenal Cortical Carcinoma

Ampulla of Vater

Anus

Appendix, Carcinoma

B

Bile Ducts, Distal

Bile Ducts, Intrahepatic

Bile Ducts, Perihilar

Bladder, Urinary

Bone

Breast

C

Cervix

Colon and Rectum

E

Esophagus and Esophagogastric Junction

G

Gallbladder

Gastrointestinal Stromal Tumor

Gestational Trophoblastic Neoplasms

K

Kidney

L

Larynx

Leukemia

Liver

Lung

Lymphoma (Hodgkin and Non-Hodgkin)

M

Melanoma of the Skin

Merkel Cell Carcinoma

Mesothelioma, Malignant Pleural

N

Nasal Cavity and Paranasal Sinuses

Nasopharynx

Neuroendocrine Tumors of the Appendix

Neuroendocrine Tumors of the Colon and Rectum

Neuroendocrine Tumors of the Pancreas

O

Oral Cavity

Oropharynx (HPV-Mediated, p16+)

Oropharynx (p16-) and Hypopharynx

Ovary, Fallopian Tube and Primary Peritoneum

P

Pancreas, exocrine

Penis

Plasma Cell Myeloma and Plasma Cell Disorders

Prostate

S

Small Intestine

Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs

Soft Tissue Sarcoma of the Head and Neck

Soft Tissue Sarcoma of the Retroperitoneum

Soft Tissue Sarcoma of the Trunk and Extremities

Soft Tissue Sarcoma Unusual Histologies and Sites

Stomach

T

Testis

U

Ureter, Renal Pelvis

Uterus, Carcinoma and Carcinosarcoma

Uterus, Sarcoma

V

Vagina

Vulva

The Galleri test is intended to detect a cancer signal and predict cancer signal's origin to inform diagnostic evaluation.

Cancer cases enrolled in CCGA Study1 were assigned a ​"cancer type" as defined in the American Joint Committee on Cancer (AJCC) manual (8th edition)2 (For this list of Cancer types detected, some of the names were modified/​edited to organize for easy reference). Cancer signals were detected across more than 50 AJCC-cancer types, which supports the potential for the Galleri test to detect a cancer signal over a diverse range of cancers across a wide biologic spectrum.

If you are a Biobalance Health® patient you can ask your Nurse Practitioner to make an appointment to have your blood drawn at our office.

The Galleri Test was created by GRAIL.